TCI Wealth Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

TCI Wealth Advisors’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-346	Closed	-$2K	–	1611
2018 Q2	$2K	Sell	346 -152	-31%	-$926	﹤0.01%	1172
2018 Q1	$3K	Hold	498	–	–	﹤0.01%	892
2017 Q4	$4K	Hold	498	–	–	﹤0.01%	857
2017 Q3	$5K	Hold	498	–	–	﹤0.01%	749
2017 Q2	$5K	Hold	498	–	–	﹤0.01%	772
2017 Q1	$4K	Hold	498	–	–	﹤0.01%	795
2016 Q4	$3K	Hold	498	–	–	﹤0.01%	946
2016 Q3	$3K	Buy	+498	New	+$2.97K	﹤0.01%	902

Other funds holding ENZ

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TCI Wealth Advisors's ENZ Position: Q3 2018 in Review

TCI Wealth Advisors sold out of Enzo Biochem, Inc. (ENZ) in Q3 2018, closing a stake of 346 shares — an estimated $2K sold.

TCI Wealth Advisors first reported a position in ENZ in Q3 2016 and held it in 8 quarters. The position peaked at $5K in Q3 2017. 101 funds tracked by Wall St. Rank hold ENZ as of Q3 2018.

TCI Wealth Advisors reported no remaining Enzo Biochem, Inc. position as of Q3 2018 after selling out during the quarter.
TCI Wealth Advisors sold 346 Enzo Biochem, Inc. shares in Q3 2018, an estimated $2K.
TCI Wealth Advisors first reported a position in Enzo Biochem, Inc. in Q3 2016 and held it in 8 quarters.
TCI Wealth Advisors's Enzo Biochem, Inc. position peaked at $5K in Q3 2017.
101 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2018.

Based on TCI Wealth Advisors's 13F filing for Q3 2018, filed 2 Nov 2018.